Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial.
Journal: American journal of obstetrics and gynecology
Published: October 27, 2023
Low-Dose Elagolix for the Treatment of Heavy Menstrual Bleeding in Patients With Uterine Leiomyomas: A Randomized Controlled Trial.
Journal: Obstetrics and gynecology
Published: October 31, 2022
Symptoms and associated impact in pre- and postmenopausal women with sexual arousal disorder: a concept elicitation study.
Journal: The journal of sexual medicine
Published: July 01, 2022
Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial.
Journal: American journal of obstetrics and gynecology
Published: April 29, 2022
Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden.
Journal: Menopause (New York, N.Y.)
Published: May 25, 2021
Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results.
Journal: Contraception
Published: December 01, 2020
Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA).
Journal: Menopause (New York, N.Y.)
Published: August 10, 2020
A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause.
Journal: Menopause (New York, N.Y.)
Published: February 27, 2020
Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
Journal: Menopause (New York, N.Y.)
Published: November 30, 2018
Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.
Journal: Obstetrics and gynecology
Published: October 11, 2018
Usability of daily SF36 questionnaires to capture the QALD variation experienced after vaccination with AS03A-adjuvanted monovalent influenza A (H5N1) vaccine in a safety and tolerability study.
Journal: Health and quality of life outcomes
Published: March 02, 2018
A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
Journal: Menopause (New York, N.Y.)
Published: September 20, 2017
Last Updated: 09/26/2026